Dapagliflozin and Metformin

Dapagliflozin and Metformin
GLIDAPAFLOZIN M are both medications used in the treatment of Type 2 diabetes.
Dapagliflozin is a medication that belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. GLIDAPAFLOZIN works by blocking the reabsorption of glucose by the kidneys, thereby increasing the amount of glucose excreted in the urine. This helps to lower blood sugar levels in people with Type 2 diabetes.
Metformin, on the other hand, is a medication that belongs to a class of drugs known as biguanides. GLIDAPAFLOZIN works by decreasing the amount of glucose produced by the liver and by improving the body's sensitivity to insulin. GLIDAPAFLOZIN  helps to lower blood sugar levels in people with Type 2 diabetes.
Both medications can be prescribed alone or in combination with other medications to help manage blood sugar levels in people with Type 2 diabetes. It's important to note that both medications have potential side effects and should be taken under the guidance of a healthcare provider.
GLIDAPAFLOZIN M is available in strengths of 5/500 & 10/500 mg.
For further information please contact:
info@sterispharma.com